The observation that Sp17+ cells are required to initiate tumor formation in the ID8 model suggests that STAT3 and PD-L1 expression may be key to this process, and that Sp17 may act as a surrogate marker for the presence of these immunosuppressive, metastatic cells in tumors. This evidence concerns the gene STAT3 and neoplasm.